Pricing and Corporate Actions Analyst

Founded in 1977, GMO is a global investment manager committed to delivering superior long-term investment performance and advice to our clients. We offer investment strategies and solutions where we believe we are positioned to add the greatest value for our investors. These include multi-asset class, equity, fixed income and alternative offerings.

We manage approximately $80bn for a client base that includes many of the world’s most sophisticated institutions, financial intermediaries, and private clients. Industry-wide, we are well known for our focus on valuation-based investing, willingness to take bold positions when conditions warrant, and candid and academically rigorous thought leadership. Jeremy Grantham, GMO’s Co-Founder and Long-Term Investment Strategist, is renowned as an expert in identifying speculative investment bubbles and also as a leading climate investor and advocate.

GMO is privately owned and employs over 430 people worldwide. We are headquartered in Boston, with additional offices in Europe, Asia and Australia. Our company-wide culture emphasizes commitment to clients, intellectual curiosity, and open debate. We celebrate and respect our differences, while embracing and valuing what each of us brings to work, as we know that diverse teams in an inclusive, caring environment achieve higher engagement and better client results.

Position Overview

Within the Pricing and Corporate Actions team, the analysts focused on corporate actions oversee the entire lifecycle of all corporate actions for GMO’s funds and separately managed accounts.  From announcement to accounting entries, the team coordinates with internal and external parties to ensure accurate reflection and timely processing of both mandatory and voluntary corporate actions.  The Pricing and Corporate Actions Analyst supports all functions related to corporate actions, while also partnering with analysts within the team focused on pricing.  The analysts focused on pricing are responsible for providing timely and accurate valuations across all securities held within GMO.  Analysts within the Pricing and Corporate Actions team are uniquely positioned to gain exposure across multiple asset classes ranging from equities and futures, fixed income, listed and unlisted derivatives and complex OTC instruments.